Literature DB >> 15077024

Decline in native renal function early after bladder-drained pancreas transplantation alone.

Marek J Mazur1, David J Rea, Matthew D Griffin, Timothy S Larson, Mikel Prieto, James M Gloor, Thomas R Schwab, Stephen C Textor, Scott L Nyberg, Mark D Stegall.   

Abstract

BACKGROUND: Pancreas transplant alone (PTA) has become accepted therapy for select nonuremic patients with type 1 diabetes mellitus. However, PTA may lead to significant complications including a decline in native renal function. This study examines trends in native renal function during the first posttransplant year in PTA recipients with a spectrum of pretransplant glomerular filtration rates (GFR).
METHODS: Renal function was studied in 23 recipients of bladder-drained PTA who underwent transplantation from April 1998 through September 2001. GFR was measured by corrected iothalamate clearance at the time of transplant evaluation and 1 year posttransplant and also calculated using the Cockcroft-Gault method at the transplant evaluation; at the day of transplantation; and at 1, 6, and 12 months posttransplant.
RESULTS: Iothalamate clearance decreased in the first year in 96% of patients (22 of 23). The mean measured GFR decreased from 84 +/- 33 mL/min/1.73 m2 pretransplant to 52 +/- 26 mL/min/1.73 m2 at 1 year (P <0.001). Calculated creatinine clearance declined in the majority of patients at both 1 and 12 months after PTA, but some patients, including a few with low GFR, maintained stable renal function. Calculated GFR generally correlated well with measured GFR in most patients, with a few notable exceptions. One patient (baseline GFR, 42 mL/min/1.73 m2) developed renal failure in the first year after transplant and required kidney transplantation.
CONCLUSIONS: Bladder-drained PTA results in a decline in native renal function in the majority of patients regardless of the pretransplant GFR. These data suggest the need for strategies to prevent or minimize the decline in renal function after PTA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15077024     DOI: 10.1097/01.tp.0000114607.62534.c9

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus.

Authors:  Kristina I Rother; David M Harlan
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 2.  Transplantation for type 1 diabetes: whole organ pancreas and islet cells.

Authors:  Martha Pavlakis; Khalid Khwaja
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

Review 3.  [Pancreas and islet transplantation. The role in the treatment of diabetes mellitus].

Authors:  P Schenker; R Viebahn
Journal:  Chirurg       Date:  2009-05       Impact factor: 0.955

Review 4.  Pancreas transplant alone: a procedure coming of age.

Authors:  Rainer W G Gruessner; Angelika C Gruessner
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

5.  Pancreas Retransplant After Pancreas Graft Failure in Simultaneous Pancreas-kidney Transplants Is Associated With Better Kidney Graft Survival.

Authors:  Sandesh Parajuli; Annamalai Arunachalam; Kurtis J Swanson; Fahad Aziz; Neetika Garg; Natalie Bath; Robert R Redfield; Dixon Kaufman; Arjang Djamali; Jon Odorico; Didier A Mandelbrot
Journal:  Transplant Direct       Date:  2019-07-23

6.  The evolution of diabetic chronic complications after pancreas transplantation.

Authors:  João R de Sá; Patricia T Monteagudo; Erika B Rangel; Cláudio S Melaragno; Adriano M Gonzalez; Marcelo M Linhares; Alcides Salzedas; Maria-Deolinda F Neves; Camila Stela; José O Medina-Pestana
Journal:  Diabetol Metab Syndr       Date:  2009-09-28       Impact factor: 3.320

7.  Long-term effects of pancreas transplant alone on nephropathy in type 1 diabetic patients with optimal renal function.

Authors:  Sung Shin; Chang Hee Jung; Ji Yoon Choi; Hyun Wook Kwon; Joo Hee Jung; Young Hoon Kim; Duck Jong Han
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.